Updated Date: Fri, 28 Jan 2022 00:00:00 EST
High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, […]
Pharma giant Sanofi continues to modernise with branding which reflects its commitment to social responsibility and sustainability
UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease […]
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it kdunleavy Fri, […]
The hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes fkansteiner Fri, […]
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms esagonowsky Fri, 02/04/2022 – 10:34
Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter fkansteiner […]
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown badams Fri, 02/04/2022 – 08:17
